Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci.

Low JS, Chin YM, Mushiroda T, Kubo M, Govindasamy GK, Pua KC, Yap YY, Yap LF, Subramaniam SK, Ong CA, Tan TY, Khoo AS; Malaysian NPC Study Group, Ng CC.

PLoS One. 2016 Jan 5;11(1):e0145774. doi: 10.1371/journal.pone.0145774. eCollection 2016.

2.

Epigenetics in Brain Tumors: HDACs Take Center Stage.

Eyüpoglu IY, Savaskan NE.

Curr Neuropharmacol. 2016;14(1):48-54.

3.

New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.

Mannion N, Arieti F, Gallo A, Keegan LP, O'Connell MA.

Biomolecules. 2015 Sep 30;5(4):2338-62. doi: 10.3390/biom5042338. Review.

4.

Neurodegeneration and the Brain Tumor Microenvironment. [corrected].

Savaskan NE, Fan Z, Broggini T, Buchfelder M, Eyüpoglu IY.

Curr Neuropharmacol. 2015;13(2):258-65. Erratum in: Curr Neuropharmacol. 2015;13(6):846.

5.

Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.

Lemée JM, Clavreul A, Menei P.

Neuro Oncol. 2015 Oct;17(10):1322-32. doi: 10.1093/neuonc/nov119. Epub 2015 Jul 22. Review.

PMID:
26203067
6.

SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.

Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM, Berens ME, Lahti AC, Nabors LB, Sontheimer H.

Sci Transl Med. 2015 May 27;7(289):289ra86. doi: 10.1126/scitranslmed.aaa8103.

7.

Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration.

Catacuzzeno L, Caramia M, Sforna L, Belia S, Guglielmi L, D'Adamo MC, Pessia M, Franciolini F.

Front Cell Neurosci. 2015 Apr 20;9:152. doi: 10.3389/fncel.2015.00152. eCollection 2015. Review.

8.

Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion.

Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson EM, Mount CW, Polepalli J, Mitra SS, Woo PJ, Malenka RC, Vogel H, Bredel M, Mallick P, Monje M.

Cell. 2015 May 7;161(4):803-16. doi: 10.1016/j.cell.2015.04.012. Epub 2015 Apr 23.

9.

Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.

von Roemeling CA, Radisky DC, Marlow LA, Cooper SJ, Grebe SK, Anastasiadis PZ, Tun HW, Copland JA.

Cancer Res. 2014 Sep 1;74(17):4796-810. doi: 10.1158/0008-5472.CAN-14-0210. Epub 2014 Jun 24.

10.

Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development.

Wangari-Talbot J, Goydos J, Chen S.

Pharmaceuticals (Basel). 2010 Aug 26;3(9):2821-2837.

11.

Glutamate and its receptors in cancer.

Stepulak A, Rola R, Polberg K, Ikonomidou C.

J Neural Transm (Vienna). 2014 Aug;121(8):933-44. doi: 10.1007/s00702-014-1182-6. Epub 2014 Mar 9. Review.

12.

A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.

Turner KL, Honasoge A, Robert SM, McFerrin MM, Sontheimer H.

Glia. 2014 Jun;62(6):971-81. doi: 10.1002/glia.22655. Epub 2014 Mar 2.

13.

Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.

Yohay K, Tyler B, Weaver KD, Pardo AC, Gincel D, Blakeley J, Brem H, Rothstein JD.

J Neurosurg. 2014 Apr;120(4):854-63. doi: 10.3171/2013.12.JNS13641. Epub 2014 Jan 31.

14.

Glutamate transporters in the biology of malignant gliomas.

Robert SM, Sontheimer H.

Cell Mol Life Sci. 2014 May;71(10):1839-54. doi: 10.1007/s00018-013-1521-z. Epub 2013 Nov 27. Review.

15.

How does cancer cell metabolism affect tumor migration and invasion?

Han T, Kang D, Ji D, Wang X, Zhan W, Fu M, Xin HB, Wang JB.

Cell Adh Migr. 2013 Sep-Oct;7(5):395-403. doi: 10.4161/cam.26345. Epub 2013 Oct 8. Review.

16.

ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding.

Wang Q, Hui H, Guo Z, Zhang W, Hu Y, He T, Tai Y, Peng P, Wang L.

RNA. 2013 Nov;19(11):1525-36. doi: 10.1261/rna.041533.113. Epub 2013 Sep 25.

17.

Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.

Yelskaya Z, Carrillo V, Dubisz E, Gulzar H, Morgan D, Mahajan SS.

PLoS One. 2013 May 27;8(5):e64588. doi: 10.1371/journal.pone.0064588. Print 2013.

18.

ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.

Tomaselli S, Galeano F, Massimi L, Di Rocco C, Lauriola L, Mastronuzzi A, Locatelli F, Gallo A.

BMC Cancer. 2013 May 22;13:255. doi: 10.1186/1471-2407-13-255.

19.

Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model.

Jacobs VL, De Leo JA.

J Neurooncol. 2013 Aug;114(1):33-42. doi: 10.1007/s11060-013-1158-7. Epub 2013 May 22.

20.

Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis.

Blaylock RL.

Surg Neurol Int. 2013;4:15. doi: 10.4103/2152-7806.106577. Epub 2013 Jan 29.

Items per page

Supplemental Content

Write to the Help Desk